Pioneering mental well-being in the workplace through advanced AI-driven solutions.
At DYAGNOSYS Health, we are dedicated to transforming how organizations understand and manage workplace mental health. Our AI-powered tools target the underlying factors of silent burnout, stress, and anxiety—challenges that impact 88% of employees globally. By leveraging real-time insights and actionable data, we help increase productivity by 30% and cut absenteeism by 33%.
2021: Founded with a vision to revolutionize mental health analytics in the workplace, we focused on extracting stress and anxiety biomarkers through advanced AI capable of interpreting voice patterns, heart rate variability, and subtle facial expressions.
2022: Early pilot programs in Brazil, coupled with strategic alliances with clinical and academic institutions, validated our approach and laid a solid foundation for future growth.
2023: With our first prototype successfully deployed, we established multinational corporate partnerships and achieved clinical validation in Switzerland, strengthening our credibility and global reach.
2024: Building on our proven methodologies, we introduced a scalable and customizable AI SaaS platform designed to assess stress and anxiety at scale— empowering diverse industries worldwide to foster healthier, more resilient workforces.
Empowering organizations and individuals through intelligence-driven mental health insights.
Our mission at DYAGNOSYS Health is to elevate workplace well-being by transforming raw data into meaningful mental health intelligence. Through continuous innovation and compassionate design, we enable organizations to realize tangible returns on investment—improving employee satisfaction, retention, and productivity.
From insightful analytics to personalized action plans, every step we take is grounded in evidence-based practices. We aim to create work environments where mental health is understood, supported, and optimized—ultimately helping companies thrive in a rapidly evolving world.
2021: Established with a mission to harness AI for mental health insights.
2022: Pilots in Brazil confirm feasibility and gain clinical endorsements.
2023: Launch of our first prototype; validated by multinational partners and Swiss studies.
2024: Scalable SaaS platform introduced, serving diverse industries worldwide.
2025: Expanding modalities and refining AI for a truly global, multi-sector impact.